Sfoglia per Autore
Virus di Epstein-Barr e linfomi primitivi cutanei: valutazione della carica virale mediante PCR quantitativa-competitiva (QC-PCR) su biopsia.
2006-01-01 Bergallo M; Costa C; Novelli M; Ponti R; Fierro MT; Margio S; Bernengo MG; Merlino C; Cavallo R.
Ruolo del virus di Epstein-Barr nei linfomi cutanei T primitivi: quantificazione dell’EBV-DNA nelle biopsie cutanee e nel sangue periferico mediante real-time PCR.
2006-01-01 Merlino C.; Bergallo M.; Costa C.; Novelli M.; Ponti R.; Fierro M.T.; Bernengo M.G.; Cavallo R.; Negro Ponzi A.
Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome
2006-01-01 M.T. FIERRO; A. COMESSATTI; P. QUAGLINO; M. ORTONCELLI; S. OSELLA ABATE; R. PONTI; M. NOVELLI; M. BERNENGO
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients.
2006-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
Primary cutaneous B-cell lymphoma - Reply
2006-01-01 Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG
Immunobiology of melanoma: the dark side of the moon?
2005-01-01 QUAGLINO P; OSELLA-ABATE S; SAVOIA P; FIERRO MT; BERNENGO MG
Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004
2005-01-01 BERNENGO MG; QUAGLINO P; CAPPELLO N; FIERRO MT; DOVEIL GC; MACRIP G; OSELLA-ABATE S; PERONI A; LISA F; SAVOIA P
T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings
2005-01-01 PONTI R; QUAGLINO P; NOVELLI M; FIERRO MT; COMESSATTI A; PERONI A; BONELLO L; BERNENGO M (PR e QP equal contribution)
Quantificazione mediante PCR dell’EBV-DNA da biopsie cutanee di pazienti con CTCL (micosi fungoide e sindrome di Sezary)
2005-01-01 Merlino C.; Bergallo M.; Costa C.; Novelli M.; Ponti R.; Fierro M.T.; Cavallo R.; Bernengo M.G.; Negro Ponzi A.
Disseminated Kaposi's sarcoma associated with idiopathic CD4+ lymphocytopenia and low dose steroid therapy
2005-01-01 MT. FIERRO; P. SAVOIA; P. QUAGLINO; D. NOVERO; M. BERNENGO
Clonal TCR-gamma gene rearrangement by multiplex pCR/heteroduplex analysis in the skin of patients with cutaneous T-cell Lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory diseases: diagnostic relevance and correlation with histological findings
2005-01-01 Quaglino P; Ponti R; Novelli M; Fierro MT; Savoia P; Comessatti A; Peroni A; Bernengo MG.
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica.
2004-01-01 Comessatti A; Novelli M; Fierro MT; Osella-Abate S; Ponti R; Quaglino P; Savoia P; Bernengo MG.
Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
2004-01-01 QUAGLINO P; FIERRO M; ROSSOTTO GL; SAVOIA P; BERNENGO MG
Alemtuzumab nel trattamento dei linfomi cutanei a cellule T in fase avanzata: studio pilota “dose finding”.
2004-01-01 Savoia P; Fierro MT; Quaglino P; Peroni A; Comessatti A; Bernengo MG.
Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study
2004-01-01 Macripo G.; Quaglino P.; Caliendo V.; Ronco A.M.; Soltani S.; Giacone E.; Pau S.; Fierro M.T.; Bernengo M.G.
Efficacia del bexarotene in un caso di micosi fungoide in fase avanzata
2004-01-01 Peroni A; Savoia P; Fierro MT
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data
2004-01-01 QUAGLINO P; SAVOIA P; FIERRO M; OSELLA-ABATE S; BERNENGO MG
Clinical significance of tyrosinase expression in the peripheral blood of stage III disease-free melanoma patient
2003-01-01 Fierro MT; Osella-Abate S; Savoia P; Quaglino P; Doveil GC; MG Bernengo
Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients.
2003-01-01 OSELLA-ABATE S; SAVOIA P; QUAGLINO P; FIERRO MT; LEPORATI C; ORTONCELLI M; M. BERNENGO
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients.
2003-01-01 Novelli M; Comessatti A;Quaglino P;Savoia P; Fierro MT; Bernengo MG.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile